Search

Your search keyword '"Power, David"' showing total 404 results

Search Constraints

Start Over You searched for: Author "Power, David" Remove constraint Author: "Power, David" Database Unpaywall Remove constraint Database: Unpaywall
404 results on '"Power, David"'

Search Results

2. The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury

6. Courage to Shape Our Future

8. Abstract 17970: Incidence and Impact of Contrast-Associated Acute Kidney Injury in High-Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention

11. TCT-168 Clinical Significance of Insulin- and Noninsulin-Dependent Diabetes in Patients Undergoing Percutaneous Revascularization of the Left Main Coronary Artery

12. TCT-509 Impact of Coronary Trifurcation Anatomy on Cardiovascular Outcomes in Unprotected Left Main Percutaneous Coronary Intervention.

13. TCT-511 Impact of Adjunctive Intravascular Imaging on Cardiovascular Outcomes in Unprotected Left Main Percutaneous Coronary Intervention at a High-Volume Center

14. TCT-626 Clinical Impact of Troponin and CK-MB Release After Percutaneous Coronary Intervention With Rotational Atherectomy: Results From a Large Prospective Registry

19. LB-10 | Predictive Value of the Thrombotic Risk Criteria of the 2020 ESC guidelines for NSTE-ACS: Validation in a Large PCI Registry

31. TCT-158 Pooled Analysis of Patients Undergoing Complex PCI With the Dual-Therapy COMBO Stent: The MEGA-COMBO Complex-PCI Analysis

34. Imaging in Percutaneous Coronary Intervention

37. CE-543-04 INTER-ATRIAL BLOCK IDENTIFIES PATIENTS WITH LOW CHA2DS2-VASC SCORE BUT HIGH STROKE RISK

40. Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina Pectoris

41. Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-sensitive Pathways

42. Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-sensitive Pathways

43. Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive Pathways

44. Cardiovascular Complications of Interatrial Conduction Block

45. IMPACT OF CORONARY ARTERY DISEASE ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL

47. IMPACT OF CHRONIC THROMBOCYTOPENIA ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL

48. SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis

Catalog

Books, media, physical & digital resources